- Home
- TNGX vs ALRM Comparison
TNGX vs ALRM Comparison
Compare TNGX & ALRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNGX | ALRM |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.4B |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | TNGX | ALRM |
|---|---|---|
| Price | $19.77 | $43.83 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 3 |
| Target Price | $21.78 | ★ $56.67 |
| AVG Volume (30 Days) | ★ 2.6M | 419.2K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.89 | 7.42 |
| EPS | N/A | ★ 0.47 |
| Revenue | $62,384,000.00 | ★ $1,011,187,000.00 |
| Revenue This Year | N/A | $7.00 |
| Revenue Next Year | N/A | $4.53 |
| P/E Ratio | ★ N/A | $93.23 |
| Revenue Growth | ★ 48.29 | 7.59 |
| 52 Week Low | $1.93 | $41.49 |
| 52 Week High | $28.41 | $59.98 |
Technical Indicators
Market Signals| Indicator | TNGX | ALRM |
|---|---|---|
| Relative Strength Index (RSI) | 39.92 | 48.05 |
| Support Level | $7.08 | $42.16 |
| Resistance Level | $22.01 | $45.12 |
| Average True Range (ATR) | 1.71 | 1.64 |
| MACD | -0.49 | 0.00 |
| Stochastic Oscillator | 4.88 | 35.20 |
Price Performance
Historical ComparisonAbout TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About ALRM Alarm.com Holdings Inc.
Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected devices.